These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22751483)

  • 1. RAS, cellular senescence and transformation: the BRCA1 DNA repair pathway at the crossroads.
    Tu Z; Aird KM; Zhang R
    Small GTPases; 2012; 3(3):163-7. PubMed ID: 22751483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic RAS regulates BRIP1 expression to induce dissociation of BRCA1 from chromatin, inhibit DNA repair, and promote senescence.
    Tu Z; Aird KM; Bitler BG; Nicodemus JP; Beeharry N; Xia B; Yen TJ; Zhang R
    Dev Cell; 2011 Dec; 21(6):1077-91. PubMed ID: 22137763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRG1 is required for formation of senescence-associated heterochromatin foci induced by oncogenic RAS or BRCA1 loss.
    Tu Z; Zhuang X; Yao YG; Zhang R
    Mol Cell Biol; 2013 May; 33(9):1819-29. PubMed ID: 23438604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D/vitamin D receptor axis regulates DNA repair during oncogene-induced senescence.
    Graziano S; Johnston R; Deng O; Zhang J; Gonzalo S
    Oncogene; 2016 Oct; 35(41):5362-5376. PubMed ID: 27041576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
    Barnoud T; Schmidt ML; Donninger H; Clark GJ
    Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential oncogenic Ras signaling and senescence in tumor cells.
    Bihani T; Mason DX; Jackson TJ; Chen SC; Boettner B; Lin AW
    Cell Cycle; 2004 Sep; 3(9):1201-7. PubMed ID: 15492501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts.
    Deng Q; Liao R; Wu BL; Sun P
    J Biol Chem; 2004 Jan; 279(2):1050-9. PubMed ID: 14593117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Mut T Homolog 1 (MTH1): a roadblock for the tumor-suppressive effects of oncogenic RAS-induced ROS.
    Rai P
    Small GTPases; 2012; 3(2):120-5. PubMed ID: 22790201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRAK is essential for ras-induced senescence and tumor suppression.
    Sun P; Yoshizuka N; New L; Moser BA; Li Y; Liao R; Xie C; Chen J; Deng Q; Yamout M; Dong MQ; Frangou CG; Yates JR; Wright PE; Han J
    Cell; 2007 Jan; 128(2):295-308. PubMed ID: 17254968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attenuation of TGF-β signaling suppresses premature senescence in a p21-dependent manner and promotes oncogenic Ras-mediated metastatic transformation in human mammary epithelial cells.
    Lin S; Yang J; Elkahloun AG; Bandyopadhyay A; Wang L; Cornell JE; Yeh IT; Agyin J; Tomlinson G; Sun LZ
    Mol Biol Cell; 2012 Apr; 23(8):1569-81. PubMed ID: 22357622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation.
    Deschênes-Simard X; Gaumont-Leclerc MF; Bourdeau V; Lessard F; Moiseeva O; Forest V; Igelmann S; Mallette FA; Saba-El-Leil MK; Meloche S; Saad F; Mes-Masson AM; Ferbeyre G
    Genes Dev; 2013 Apr; 27(8):900-15. PubMed ID: 23599344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence.
    Hong L; Lai M; Chen M; Xie C; Liao R; Kang YJ; Xiao C; Hu WY; Han J; Sun P
    Cancer Res; 2010 Nov; 70(21):8547-57. PubMed ID: 20851997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
    Shin J; Yang J; Lee JC; Baek KH
    Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A RAS-CaMKKβ-AMPKα2 pathway promotes senescence by licensing post-translational activation of C/EBPβ through a novel 3'UTR mechanism.
    Basu SK; Gonit M; Salotti J; Chen J; Bhat A; Gorospe M; Viollet B; Claffey KP; Johnson PF
    Oncogene; 2018 Jun; 37(26):3528-3548. PubMed ID: 29563610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic ras and p53 cooperate to induce cellular senescence.
    Ferbeyre G; de Stanchina E; Lin AW; Querido E; McCurrach ME; Hannon GJ; Lowe SW
    Mol Cell Biol; 2002 May; 22(10):3497-508. PubMed ID: 11971980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase D1 is essential for Ras-induced senescence and tumor suppression by regulating senescence-associated inflammation.
    Wang P; Han L; Shen H; Wang P; Lv C; Zhao G; Niu J; Xue L; Wang QJ; Tong T; Chen J
    Proc Natl Acad Sci U S A; 2014 May; 111(21):7683-8. PubMed ID: 24828530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ras-induced senescence and its physiological relevance in cancer.
    Dimauro T; David G
    Curr Cancer Drug Targets; 2010 Dec; 10(8):869-76. PubMed ID: 20718709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms.
    Kwong J; Hong L; Liao R; Deng Q; Han J; Sun P
    J Biol Chem; 2009 Apr; 284(17):11237-46. PubMed ID: 19251701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence.
    Kolesnichenko M; Hong L; Liao R; Vogt PK; Sun P
    Cell Cycle; 2012 Jun; 11(12):2391-401. PubMed ID: 22627671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JMJD2A promotes cellular transformation by blocking cellular senescence through transcriptional repression of the tumor suppressor CHD5.
    Mallette FA; Richard S
    Cell Rep; 2012 Nov; 2(5):1233-43. PubMed ID: 23168260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.